Characterisation of a novel group B oncolytic adenovirus, ColoAd1
<p>Developing high potent oncolytic virus with multimodal antitumour capabilities is crucial for realizing the full potential of oncolytic virotherapy in cancer treatment. ColoAd1 is a novel replicating chimeric group B adenovirus recently bioselected from a large library of recombinant virus...
Tác giả chính: | |
---|---|
Tác giả khác: | |
Định dạng: | Luận văn |
Ngôn ngữ: | English |
Được phát hành: |
2011
|
Những chủ đề: |